Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Human Molecular Genetics

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddt028PMID 23364049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oligodendroglia metabolically support axons and contribute to neurodegeneration

  2012cited by this paper
• The NAD-dependent deacetylase SIRT2 is required for programmed necrosis

  2012cited by this paper
• SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo

  2012cited by this paper
• Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease

  2011cited by this paper
• The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS.

  2011cited by this paper
• HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease

  2011influential reference
• Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling

  2011cited by this paper
• Deficits in axonal transport precede ALS symptoms in vivo

  2010cited by this paper
• SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis

  2010cited by this paper
• Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy

  2010cited by this paper
• Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

  2009cited by this paper
• Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.

  2008cited by this paper
• Microtubule Deacetylases, SirT2 and HDAC6, in the Nervous System

  2007cited by this paper
• Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.

  2007cited by this paper
• Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington's Disease by Increasing Tubulin Acetylation

  2007influential reference
• HDAC6 at the Intersection of Autophagy, the Ubiquitin-proteasome System, and Neurodegeneration

  2007cited by this paper
• Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

  2007cited by this paper
• Histone Deacetylase 6 Regulates Growth Factor-Induced Actin Remodeling and Endocytosis

  2007cited by this paper
• HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS

  2007cited by this paper
• Sirtuin 2, a Mammalian Homolog of Yeast Silent Information Regulator-2 Longevity Regulator, Is an Oligodendroglial Protein That Decelerates Cell Differentiation through Deacetylating α-Tubulin

  2007cited by this paper
• ALS: a disease of motor neurons and their nonneuronal neighbors.

  2006cited by this paper
• Microtubule acetylation promotes kinesin-1 binding and transport.

  2006cited by this paper
• Review ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

  2006cited by this paper
• Axonal transport and neurodegenerative disease.

  2006cited by this paper
• HDAC6 and Microtubules Are Required for Autophagic Degradation of Aggregated Huntingtin*

  2005influential reference
• Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis

  2004cited by this paper
• The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.

  2003cited by this paper
• The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.

  2003cited by this paper
• Sexual differences in onset of disease and response to exercise in a transgenic model of ALS.

  2003cited by this paper
• [The ubiquitin-proteasome system and neurodegeneration].

  2001cited by this paper
• Increase in diameter of the axonal initial segment is an early change in amyotrophic lateral sclerosis.

  1992cited by this paper
• Van Damme A.

  1986cited by this paper

• Elevated Serum SIRT2 Is Associated With Rapid Progression and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

  2026cites this paper
• Tubulin Acetylation and the Cellular Mechanosensing and Stress Response.

  2025cites this paper
• Tubulin Acetylation: A Critical Regulator of Microtubule Function.

  2025cites this paper
• Mutations in NEK1 cause ciliary dysfunction as a novel pathogenic mechanism in amyotrophic lateral sclerosis

  2025cites this paper
• Histone Deacetylase 6 Brain PET in Amyotrophic Lateral Sclerosis‐Frontotemporal Spectrum Disorder

  2025cites this paper
• Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis

  2025cites this paper
• Lysine deacetylation inhibition reverses TDP-43 mislocalization and in combination with arimoclomol ameliorates neuromuscular pathology

  2025cites this paper
• Neurodegenerative diseases: Epigenetic regulatory mechanisms and therapeutic potential.

  2025cites this paper
• Machine learning hypothesis-generation for patient stratification and target discovery in rare disease: our experience with Open Science in ALS

  2024cites this paper
• Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders

  2024cites this paper
• Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights

  2024cites this paper
• HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS

  2024cites this paper
• Current neuroprotective therapies and future prospects for motor neuron disease.

  2024cites this paper
• Distinct transcriptomic profile of satellite cells contributes to preservation of neuromuscular junctions in extraocular muscles of ALS mice

  2024cites this paper
• The Protein Acetylation after Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities

  2024cites this paper
• Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease

  2024cites this paper
• Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation

  2023cites this paper
• Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery

  2023cites this paper
• Genomic and transcriptomic advances in amyotrophic lateral sclerosis.

  2023cites this paper
• Virtual screening for early identification of potent and selective histone deacetylase 6 inhibitor series.

  2023cites this paper
• Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis

  2023cites this paper
• Chemical screens in aging-relevant human motor neurons identify MAP4Ks as therapeutic targets for amyotrophic lateral sclerosis

  2023cites this paper
• Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology

  2023cites this paper
• Pharmacological inhibition of HDAC6 downregulates TGF-β via Smad2/3 acetylation and improves dystrophin-deficient muscles

  2022cites this paper
• [HDAC6, a very specific deacetylase with a potential therapeutic role].

  2022cites this paper
• Histone Deacetylase Inhibitors As Cognitive Enhancers And Modifiers Of Mood And Behavior.

  2022cites this paper
• Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation

  2022cites this paper
• Biological networks and complexity in early-onset motor neuron diseases

  2022cites this paper
• Defective axonal transport of endo‐lysosomes and dense core vesicles in a Drosophila model of C9‐ALS/FTD

  2022cites this paper
• Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?

  2022cites this paper
• Macrophage migration inhibitory factor (MIF) acetylation protects neurons from ischemic injury

  2022cites this paper
• Cytoskeleton saga: Its regulation in normal physiology and modulation in neurodegenerative disorders.

  2022cites this paper
• Bimodal regulation of axonal transport by the GDNF-RET signalling axis in healthy and diseased motor neurons

  2022cites this paper
• The Role of Axonal Transport in Glaucoma

  2022cites this paper
• Immunosuppression Induced by Brain-Specific HDAC6 Knockdown Improves Aging Performance in Drosophila melanogaster

  2022cites this paper
• Direct and indirect effects of tubulin post-translational modifications on microtubule stability: Insights and regulations.

  2022cites this paper
• HDAC6 Inhibition Corrects Electrophysiological and Axonal Transport Deficits in a Human Stem Cell-Based Model of Charcot-Marie-Tooth Disease (Type 2D).

  2021cites this paper
• Protein lysine acetylation and its role in different human pathologies: a proteomic approach

  2021cites this paper
• Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis

  2021cites this paper
• Therapeutic Strategies for Mutant SPAST-Based Hereditary Spastic Paraplegia

  2021cites this paper
• A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?

  2021cites this paper
• Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders

  2021cites this paper
• Sirtuin Acetylation and Deacetylation: a Complex Paradigm in Neurodegenerative Disease

  2021cites this paper
• Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches

  2021cites this paper
• Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

  2021cites this paper
• Autophagy regulation by acetylation—implications for neurodegenerative diseases

  2021cites this paper
• Histone deacetylase in neuropathology.

  2021cites this paper
• Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders.

  2020cites this paper
• Amyotrophic Lateral Sclerosis Modifiers in Drosophila Reveal the Phospholipase D Pathway as a Potential Therapeutic Target

  2020cites this paper
• The Role of HDAC6 in TDP-43-Induced Neurotoxicity and UPS Impairment

  2020cites this paper
• Tubulin post‐translational modifications control neuronal development and functions

  2020cites this paper
• A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot–Marie–Tooth disease type 1A

  2020cites this paper
• Aggresome formation and liquid–liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43

  2020cites this paper
• Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases

  2020cites this paper
• Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis

  2020cites this paper
• Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment

  2020cites this paper
• Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain

  2020cites this paper
• Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications.

  2020cites this paper
• Targeting Axonal Transport: A New Therapeutic Avenue for ALS

  2020cites this paper
• Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence

  2019cites this paper
• ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.

  2019cites this paper
• Aggregation of the nucleic acid–binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation

  2019cites this paper
• Disrupted neuronal trafficking in amyotrophic lateral sclerosis

  2019cites this paper
• HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem Cell-Derived Neurons

  2019cites this paper
• Ultrastructural characterization of microtubules at high resolution in the mammalian peripheral nervous system

  2019cites this paper
• Epigenetic Pharmacology in Regenerative Medicine (Epi-Drugs)

  2019cites this paper
• Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model

  2019cites this paper
• Implications of HDACs in Neurological Disorders

  2019cites this paper
• Investigating the role of the insulin-like growth factor receptor (IGF1R) on axonal transport as a target for pharmacological intervention in Amyotrophic Lateral Sclerosis

  2019cites this paper
• Axonal transport and neurological disease

  2019cites this paper
• Acetylation of tubulin: A feasible protective target from neurodevelopment to neurodegeneration

  2019cites this paper
• A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)

  2019cites this paper
• Novel therapeutic targets for amyotrophic lateral sclerosis

  2019cites this paper
• SIRT2‐knockdown rescues GARS‐induced Charcot‐Marie‐Tooth neuropathy

  2019cites this paper
• Sirtuins in Neuroendocrine Regulation and Neurological Diseases

  2018cites this paper
• Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?

  2018cites this paper
• Coordination of microtubule acetylation and the actin cytoskeleton by formins

  2018cites this paper
• Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B‐cell lymphoma

  2018cites this paper
• Complex neuroprotective and neurotoxic effects of histone deacetylases

  2018cites this paper
• A De Novo RAPGEF2 Variant Identified in a Sporadic Amyotrophic Lateral Sclerosis Patient Impairs Microtubule Stability and Axonal Mitochondria Distribution

  2018cites this paper
• Epothilone D accelerates disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis

  2018cites this paper
• Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS

  2018cites this paper
• HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease

  2018cites this paper
• Dynamic localization of α-tubulin acetyltransferase ATAT1 through the cell cycle in human fibroblastic KD cells

  2018cites this paper
• Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome.

  2018cites this paper
• Small-molecule Modulation of HDAC6 Activity: The Propitious Therapeutic Strategy to Vanquish Neurodegenerative Disorders.

  2017cites this paper
• Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice.

  2017cites this paper
• Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?

  2017influential citation
• Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.

  2017cites this paper
• HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients

  2017cites this paper
• Genetic disruption of tubulin acetyltransferase, αTAT1, inhibits proliferation and invasion of colon cancer cells through decreases in Wnt1/β-catenin signaling.

  2017cites this paper
• Microtubule-Directed Therapeutic Strategy for Neurodegenerative Disorders: Starting From the Basis and Looking on the Emergences.

  2017cites this paper
• A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease.

  2016cites this paper
• Autophagy Enhancers, are we there Yet?

  2016cites this paper
• Stress granules at the intersection of autophagy and ALS.

  2016cites this paper
• The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.

  2016cites this paper
• Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.

  2016cites this paper
• Back to the tubule: microtubule dynamics in Parkinson’s disease

  2016influential citation
• Cellular Signature of SIL1 Depletion: Disease Pathogenesis due to Alterations in Protein Composition Beyond the ER Machinery

  2016cites this paper
• Immune response in peripheral axons delays disease progression in SOD1G93A mice

  2016cites this paper